crsf 07th masterclass: egfr mutated lung cancer | dr. amit dutt on ngs interpretation for clinicians
Published 1 month ago • 16 plays • Length 15:06Download video MP4
Download video MP3
Similar videos
-
12:57
crsf 07th masterclass: first-line tki combination therapy in egfr mutated lung cancer | dr. turkar
-
23:40
dr. amit dutt | translating cancer genomics to clinical practice | crsf 07th lung cancer masterclass
-
15:45
dr. vidya veldore | egfr (t790 and c797s) mutations | crsf 07th lung cancer masterclass
-
14:03
crsf 07th masterclass: interpretation of alk in lung cancer | dr. s p shrivastava
-
23:31
07th masterclass: panel discussion on maximizing osimertinib outcomes in egfrm lung cancer | dr. pai
-
10:37
crsf 07th masterclass in lung cancer | dr. minit shah on adjuvant io in locally advanced lalc
-
20:30
panel discussion: advances in lung cancer treatment | crsf 2023 review
-
23:17
expert panel discussion: latest insights in lung cancer treatment | crsf 2023 review
-
25:15
crsf 7th masterclass | car-t cell therapy in lung cancer by dr. vijay patil | day 3
-
8:55
crsf 7th masterclass | exon 20 insertion interpretation in lung cancer by dr. amit verma | day 3
-
19:30
crsf 07th masterclass in lung cancer | dr. t.p. sahoo on managing actionable mutations in lalc
-
17:51
crsf 07th masterclass in lung cancer | dr. srinivas chilukuri on radiation in locally advanced lalc
-
17:18
crsf 07th masterclass in lung cancer | dr. mounika boppana on neoadjuvant io in advanced nsclc
-
30:28
07th masterclass:dr. sewanti limaye optimal sequencing of alk tkis in alk mnsclc | panel discussion
-
19:05
crsf 7th masterclass | staging of lung cancer: a comprehensive guide to diagnosis and treatment
-
40:47
crsf 7th masterclass | dr. akhil kapoor on immunotherapy in older adults with lung cancer
-
15:00
crsf 07th masterclass in lung cancer | dr. bivas biswas on maintenance therapy in stage iii nsclc
-
8:09
crsf 7th masterclass | first-line therapy for ntrk lung cancer by dr. bhavesh poladia
-
19:41
crsf 7th masterclass | panel on egfr & kras therapies: dr. akhil kapoor & experts discuss
-
13:53
dr alok goel | post osimeritinib options in egfr mutated lung cancer | crsf